Evidence required to evaluate the use of bacteriologically confirmed asymptomatic tuberculosis disease as a primary endpoint in prevention of tuberculosis disease vaccine licensure trials

Overview of attention for article published in The Lancet Respiratory Medicine, July 2025

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 12 X users

bluesky: 16 Bluesky users

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 45,903 followers.

RT @TB_UITB: Evidence required to evaluate the use of bacteriologically confirmed asymptomatic TB disease as a primary endpoint in preventi…

Evidence required to evaluate the use of bacteriologically confirmed asymptomatic TB disease as a primary endpoint in prevention of TB disease vaccine licensure trials ➡️➡️ it could lead to cheaper and more rapid TB vaccine development https://t.co/UU…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 8 additional X posts.